Skip to main content
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy.
Published Web Location
http://europepmc.org/articles/PMC4102809?pdf=renderNo data is associated with this publication.
Abstract
Phosphatase and tensin homolog (PTEN) loss is associated with genomic instability. APE1 is a key player in DNA base excision repair (BER) and an emerging drug target in cancer. We have developed small molecule inhibitors against APE1 repair nuclease activi
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.